(Q37164669)

18 August 2017

1 reference

title

Protective effects of cilostazol against transient focal cerebral ischemia and chronic cerebral hypoperfusion injury (English)

1 reference

18 August 2017

1 reference

Jeong Hyun Lee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494013&resulttype=core&format=json

14 May 2020

So Youn Park

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494013&resulttype=core&format=json

14 May 2020

Hwa Kyoung Shin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494013&resulttype=core&format=json

14 May 2020

Chi Dae Kim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494013&resulttype=core&format=json

14 May 2020

Won Suk Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494013&resulttype=core&format=json

14 May 2020

Ki Whan Hong

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494013&resulttype=core&format=json

14 May 2020

publication date

1 January 2008

1 reference

CNS Neuroscience & Therapeutics

18 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494013&resulttype=core&format=json

14 May 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494013&resulttype=core&format=json

14 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494013&resulttype=core&format=json

14 May 2020

page(s)

143-152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494013&resulttype=core&format=json

Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Alterations in glia and axons in the brains of Binswanger's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Stroke: antithrombin versus antiplatelet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Neuropsychological correlates of white-matter lesions in healthy elderly subjects. A threshold effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Mitochondrial dysfunction and oxidative stress as determinants of cell death/survival in stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

The maxi-K channel opener BMS-204352 attenuates regional cerebral edema and neurologic motor impairment after experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Coronary stent restenosis in patients treated with cilostazol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

What have we learned from recent antiplatelet trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

CREB couples neurotrophin signals to survival messages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Cilostazol attenuates gray and white matter damage in a rodent model of focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Cilostazol prevents tumor necrosis factor-alpha-induced cell death by suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and activation of Akt/cyclic AMP response element-binding protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Pharmacoeconomic analysis of cilostazol for the secondary prevention of cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Cilostazol as a Unique Antithrombotic Agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Cilostazol enhances casein kinase 2 phosphorylation and suppresses tumor necrosis factor-alpha-induced increased phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and apoptotic cell death in SK-N-SH cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

White matter changes in the gerbil brain under chronic cerebral hypoperfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Potassium channel openers as potential therapeutic weapons in ion channel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Cilostazol reduces brain lesion induced by focal cerebral ischemia in rats--an MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Cilostazol prevents focal cerebral ischemic injury by enhancing casein kinase 2 phosphorylation and suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-alpha formation in low-density lipoprotein receptor-null mice fed high cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Neuroprotection by cilostazol, a phosphodiesterase type 3 inhibitor, against apoptotic white matter changes in rat after chronic cerebral hypoperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Poly(ADP-ribose) polymerase inhibition by cilostazol is implicated in the neuroprotective effect against focal cerebral ischemic infarct in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Antiplatelet agents for secondary prevention of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Cerebral white matter is highly vulnerable to ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein rece

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Cilostazol suppresses superoxide production and expression of adhesion molecules in human endothelial cells via mediation of cAMP-dependent protein kinase-mediated maxi-K channel activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Selective glial vulnerability following transient global ischemia in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Nuclear translocation of apoptosis-inducing factor after focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Comparison of the effects of cilostazol and milrinone on cAMP-PDE activity, intracellular cAMP and calcium in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Alteration of second messengers during acute cerebral ischemia - adenylate cyclase, cyclic AMP-dependent protein kinase, and cyclic AMP response element binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Cilostazol reduces ischemic brain damage partly by inducing metallothionein-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

A cyclooxygenase-2 inhibitor attenuates white matter damage in chronic cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Is CREB a key to neuronal survival?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Cilostazol, a phosphodiesterase 3 inhibitor, protects mice against acute and late ischemic brain injuries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2008.00042.X

Comparative study of antiplatelet drugs in vitro: distinct effects of cAMP-elevating drugs and GPIIb/IIIa antagonists on thrombin-induced platelet responses

21 January 2018

1 reference

12 December 2020

CREB phosphorylation promotes nerve cell survival

1 reference

12 December 2020

Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery

1 reference

12 December 2020

Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice

1 reference

12 December 2020

Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease

1 reference

12 December 2020

Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain

1 reference

12 December 2020

Glial cell type-specific responses to menadione-induced oxidative stress

1 reference

12 December 2020

Neurotrophins require distinct extracellular signals to promote the survival of CNS neurons in vitro

1 reference

12 December 2020

Presynaptic calcium signals and transmitter release are modulated by calcium-activated potassium channels

1 reference

12 December 2020

Poly(ADP-ribose) polymerase inhibition protect neurons and the white matter and regulates the translocation of apoptosis-inducing factor in stroke.

1 reference

12 December 2020

Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction

1 reference

12 December 2020

Varieties of calcium-activated potassium channels

1 reference

12 December 2020

Production of tumor necrosis factor-alpha by microglia and astrocytes in culture

1 reference

12 December 2020

The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man.

1 reference

12 December 2020

Effect of cilostazol on platelet aggregation and experimental thrombosis

1 reference

12 December 2020

Early changes in blood brain barrier permeability to small molecules after transient cerebral ischemia

1 reference

12 December 2020

Evolution of Regional Changes in Apparent Diffusion Coefficient during Focal Ischemia of Rat Brain: The Relationship of Quantitative Diffusion NMR Imaging to Reduction in Cerebral Blood Flow and Metabolic Disturbances

1 reference

12 December 2020

Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: an immunohistochemical study.

1 reference

12 December 2020

Alterations in cerebral endothelial cell function in ischemia

1 reference

12 December 2020

Relationship between cholinergic dysfunction and discrimination learning disabilities in Wistar rats following chronic cerebral hypoperfusion.

1 reference

12 December 2020

Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system

1 reference

12 December 2020

Inhibition of shear stress-induced platelet aggregation by cilostazol, a specific inhibitor of cGMP-inhibited phosphodiesterase, in vitro and ex vivo

1 reference

12 December 2020

Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial

1 reference

12 December 2020

10.1111/J.1527-3458.2008.00042.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494013&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494013&resulttype=core&format=json

14 May 2020

1 reference